A recent study obtained from integrated analyses of methylated-differentially expressed genes in primary GBM revealed that S100A4 was one of the most significant hypomethylated/overexpressed genes characterizing the tumor, and that its elevated levels were associated with poor overall survival in GBM patients [51]. This evidence concerns the gene S100A4 and neoplasm.